Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
TARO [NYSE]
Taro Pharmaceutical Industries Ltd.
Index- P/E17.82 EPS (ttm)7.91 Insider Own65.84% Shs Outstand42.83M Perf Week2.97%
Market Cap6.04B Forward P/E11.93 EPS next Y11.82 Insider Trans- Shs Float13.33M Perf Month-11.45%
Income348.00M PEG1.15 EPS next Q- Inst Own13.50% Short Float0.29% Perf Quarter-3.11%
Sales736.30M P/S8.20 EPS this Y36.30% Inst Trans0.84% Short Ratio0.38 Perf Half Y27.33%
Book/sh25.23 P/B5.59 EPS next Y11.19% ROA31.70% Target Price150.00 Perf Year78.73%
Cash/sh15.35 P/C9.19 EPS next 5Y15.50% ROE39.90% 52W Range76.40 - 165.30 Perf YTD42.55%
Dividend- P/FCF20.07 EPS past 5Y21.30% ROI33.60% 52W High-14.71% Beta0.65
Dividend %- Quick Ratio3.90 Sales past 5Y16.40% Gross Margin75.90% 52W Low84.53% ATR5.69
Employees1342 Current Ratio4.40 Sales Q/Q-15.00% Oper. Margin55.30% RSI (14)39.31 Volatility4.90% 4.00%
OptionableYes Debt/Eq0.02 EPS Q/Q-18.20% Profit Margin55.20% Rel Volume1.42 Prev Close141.00
ShortableYes LT Debt/Eq0.01 EarningsMay 19 Payout0.00% Avg Volume100.81K Price140.98
Recom2.00 SMA20-5.03% SMA50-7.79% SMA20012.56% Volume141,400 Change-0.01%
25-Aug-14 10:20AM  Lessons To Take From Health Care's Strong 2014 And What To Buy Now at Forbes
12-Aug-14 04:59PM  Large Cap All Time Highs Today... Yahoo Finance Blogs
07-Aug-14 06:47PM  Taro Provides Results for Quarter Ended June 2014 Business Wire
06:38PM  Small-Cap Funds Are In A Lull at Investor's Business Daily
04-Aug-14 05:05PM  Taro to Announce Results for Quarter Ended June 30, 2014 Business Wire
31-Jul-14 09:03AM  4 Stocks Spiking on Big Volume at TheStreet
28-Jul-14 09:07AM  War and peace, and Israel's stock market at CNBC
09-Jul-14 01:04PM  TARO PHARMACEUTICAL INDUSTRIES LTD Financials EDGAR Online Financials
09:45AM  Today Taro Pharmaceutical Industries (TARO) Hits New Lifetime High at TheStreet
08-Jul-14 07:42PM  Taro Annual Report For Fiscal Year Ended March 31, 2014 on Form 20-F Available Business Wire
02-Jul-14 09:05AM  Taro Pharmaceuticals: Last Week's Move Is Only The Beginning at Seeking Alpha
01-Jul-14 05:19PM  Salix Pharma Hits A New High On Bullish Clinical-Trial Data Investor's Business Daily
27-Jun-14 06:02PM  NYSE stocks posting largest percentage increases +16.65%
26-Jun-14 06:41PM  Novo, Other Medicals Display Healthy Action at Investor's Business Daily
13-Jun-14 05:18PM  Why I'm Avoiding Taro Pharmaceuticals at Motley Fool
29-May-14 08:29AM  Taro: The Best Opportunity In Pharma at Seeking Alpha
28-May-14 12:16PM  Can Taro Pharmaceuticals Inject Some Growth Into Your Portfolio? at Wall St. Cheat Sheet
27-May-14 05:09PM  Taro Provides Results for Year Ended March 31, 2014 Business Wire
23-May-14 05:11PM  Actavis Builds Base As Annual Earnings Keep Growing at Investor's Business Daily
19-May-14 05:00PM  Taro to Announce Results for Quarter and Year Ended March 31, 2014 Business Wire
04-Apr-14 05:28PM  Mylan Bid Gets Rejected, But Generic-Drugmaker Rises at Investor's Business Daily
27-Mar-14 05:05PM  Taro Announces Results of Its Extraordinary General Meeting of Shareholders Business Wire
20-Mar-14 01:25PM  BlueMountain Capital Management, LLC Urges Minority Shareholders of Taro Pharmaceutical Industries Ltd. to Vote FOR BlueMountain's Independent External Nominees to the Board of Taro and AGAINST the Re-Election of Incumbent External Director PR Newswire
18-Mar-14 03:10PM  Glass Lewis Recommends Taro Pharmaceutical Shareholders Vote FOR BlueMountain Capital Management's External Director Nominees at Upcoming Extraordinary General Meeting PR Newswire
17-Mar-14 04:37PM  ISS Recommends Taro Pharmaceutical Shareholders Vote FOR BlueMountain Capital Management's External Director Nominees at Upcoming Extraordinary General Meeting PR Newswire
07-Mar-14 04:13PM  Caesarstone, Check Point Show Strong Fundamentals Optionetics
21-Feb-14 02:40PM  Ascending Base Can Launch Big Gain In Choppy Markets Investor's Business Daily
10-Feb-14 05:40PM  Generic-Drug Makers Actavis, Mylan To Report Q4 Soon Optionetics
05:05PM  Taro Provides Results for December 31, 2013 Business Wire
07:07AM  Q3 2014 Taro Pharmaceutical Industries Ltd Earnings Release - After Market Close CCBN
03-Feb-14 08:30AM  Taro to Announce Results for Quarter Ended December 31, 2013 Business Wire
31-Jan-14 07:04PM  BlueMountain Capital Management and IsZo Capital To Update Shareholders Regarding Lawsuit Against Taro Pharmaceutical Industries, Call for the Resignation of External Directors PR Newswire
29-Jan-14 11:29AM  Taro: A Beautiful Ugly Duckling at Seeking Alpha
23-Jan-14 05:05PM  Taro Schedules Extraordinary General Meeting for March 27, 2014 Business Wire
08-Jan-14 06:08PM  Actavis, Perrigo Pace Strong Generic Drugs Group Optionetics
31-Dec-13 02:36PM  3 Health Care Stocks Wall Street Is Buying at Motley Fool
30-Dec-13 07:15AM  Taro Announces Final Results of Its Self-Tender Offer Business Wire
29-Dec-13 03:06AM  U.S. Housing Gains Spur 206% Caesarstone Rally: Israel Overnight at Bloomberg
24-Dec-13 08:08AM  Taro Pharmaceutical announces preliminary results of self-tender offer theflyonthewall.com
08:08AM  Taro Announces Preliminary Results of Its Self-Tender Offer Business Wire
25-Nov-13 06:03AM  InPlay: Taro Pharm announced that it has commenced a modified 'Dutch auction' tender offer to repurchase up to $200 million of its ordinary shares at a price not greater than $97.50 per share nor less than $84.50 per share Briefing.com +6.92%
06:00AM  Taro Announces Commencement of Tender Offer to Repurchase up to $200 Million of Its Ordinary Shares Business Wire
21-Nov-13 05:04PM  BlueMountain Capital Management and IsZo Capital File Lawsuit Against Taro Pharmaceutical Industries Ltd. to Revoke the Results of the September 12, 2013 General Meeting PR Newswire
13-Nov-13 10:32PM  India's Sun Pharma raises 2013/14 revenue outlook to 25 pct Reuters +12.49%
09:48AM  TABLE-India's Sun Pharma Sept-qtr net profit surges Reuters
12-Nov-13 05:15PM  Taro Provides Results for September 30, 2013 Business Wire
07:07AM  Q2 2014 Taro Pharmaceutical Industries Ltd Earnings Release - After Market Close CCBN
31-Oct-13 04:23PM  Taro to Announce Results for Quarter Ended September 30, 2013 Business Wire
30-Oct-13 03:26PM  Teva Bids Adieu to CEO, Gives Back October Gains at Barrons.com
01-Oct-13 11:01AM  A Questionable Proxy Vote, Credit Suisse Coverage And Why Taro Is The Best Value Under The 'Sun' at Seeking Alpha
26-Sep-13 06:09PM  NYSE stocks posting largest volume increases AP +5.84%
19-Sep-13 04:45PM  Drug Firm Actavis Eyes Growth From A Buyout, Lidoderm at Investor's Business Daily
16-Sep-13 01:07PM  Wall Street Transcript Interview with Dr. Andrew Baum, Group Head of Health Care Research at Citigroup: Big Pharma Provides an Attractive Return Profile Trading at 12.5x and 3% Dividend Yield Wall Street Transcript
13-Sep-13 05:15PM  Taro Announces Results of Its Annual General Meeting of Shareholders Business Wire
12:49PM  John L. McManus, the President and CEO of Aeolus Pharmaceuticals, Inc. (AOLS), Interviews with The Wall Street Transcript Wall Street Transcript
12:16PM  BlueMountain Capital Management Demands that Taro Pharmaceutical Industries LTD Publicly Disclose the Results of the Shareholder Vote Held at Its Annual General Meeting PR Newswire
11-Sep-13 11:37AM  Actavis, Warner Chilcott Take Another Step Forward at Investor's Business Daily
04-Sep-13 05:29PM  Glass Lewis Recommends Taro Shareholders Vote for the Two Incumbent External Directors Business Wire
04:04PM  Raging Capital Management Supports Vote "FOR" Election of BlueMountain Capital's External Director Nominees at Taro Pharmaceutical Annual General Meeting of Shareholders PR Newswire
03-Sep-13 04:36PM  BlueMountain Capital says ISS supports director nominees for Taro board theflyonthewall.com
04:32PM  BlueMountain Capital Management Announces that ISS Recommends Taro Pharmaceutical Shareholders Vote FOR the BlueMountain External Director Nominees at Upcoming Annual General Meeting PR Newswire
30-Aug-13 12:30PM  A Lesson for Boardroom Battles at New York Times
26-Aug-13 12:27PM  BlueMountain Capital Management, LLC Urges Minority Shareholders to Vote For BlueMountain's Independent External Nominees to the Board of Taro Pharmaceutical Industries Ltd. and Against the Re-Election of Incumbent External Directors and Al PR Newswire
13-Aug-13 09:47AM  Bluemountain Nominates 2 To Taro's Board: Why We're Bullish at Seeking Alpha
08-Aug-13 05:05PM  Taro to Defer Annual General Meeting to September 12, 2013 Business Wire
09:09AM  Indian shares snap 2 days of losses, Ranbaxy soars on U.S. sales at Reuters
07:53AM  Indian shares snap 2 days of losses, Ranbaxy soars on U.S. sales at Reuters
07-Aug-13 05:20PM  Taro Provides Results for Quarter Ended June 2013 Business Wire
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. The company sells and distributes its products to drug wholesalers and store chains, mass merchandisers, food and retail chains, managed care organizations, generic drug distributors, and others. Taro Pharmaceutical Industries Ltd. was founded in 1959 and is based in Haifa Bay, Israel.